Clinical trial
Soy Isoflavones and Breast Cancer Risk Reduction
NCT00204490 · The University of Texas Medical Branch, Galveston, Other · Completed
Key facts
| NCT number | NCT00204490 |
|---|---|
| Title | Soy Isoflavones and Breast Cancer Risk Reduction |
| Official title | Mammographic Density and Soy Isoflavones |
| Lead sponsor | The University of Texas Medical Branch, Galveston, Other |
| Collaborators | National Cancer Institute (NCI) NIH National Center for Research Resources (NCRR) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Dietary Supplement |
| Interventions | isoflavones, carbohydrate |
| Enrollment | 197 |
| Start date | Apr 1, 2004 |
| Primary completion | Dec 10, 2012 |
| Completion | May 31, 2023 |
| First posted | Sep 20, 2005 |
| Last update posted | May 16, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: